ArticleJournal of oncology2022

CKAP2L Promotes Esophageal Squamous Cell Carcinoma Progression and Drug-Resistance by Modulating Cell Cycle.

Wenhu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.